Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT05782426 2023-03-23

Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC

Phase 2 Unknown

28 enrolled

Thoracic

Non-squamous NSCLC

NCT04571632 2022-09-14

Luscid

Phase 2 Unknown

36 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04840290 2021-04-21

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Phase 3 Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02667743 2021-03-17

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

Phase 3 Unknown

454 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04203485 2020-05-08

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 3 Unknown

762 enrolled

Thoracic

PD-L1 Positive Non-small Cell Lung Cancer

NCT04167774 2019-11-22

Compass-001

Phase 2 Unknown

62 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03083743 2017-03-20

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

Phase 3 Unknown

417 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Thoracic Neoplasms

NCT01660399 2015-12-22

Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy

Phase 2 Unknown

300 enrolled

Thoracic

Squamous Cell Lung Cancer

NCT02066870 2015-03-13

Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI

Phase 1 Unknown

9 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02223611 2014-08-22

S1VSNP

Phase 2 Unknown

100 enrolled

Thoracic

Non-small Cell Lung Cancer Stage Ⅱ

Clinical Trials

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC

Luscid

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

Compass-001

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy

Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI

S1VSNP